Menlo Park, California, 94025, United States
NCT Number: NCT00820300
A Safety Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open Angle Glaucoma
The purpose of this study is to determine if the Punctal Plug Delivery System is safe and effective in controlling intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–90 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 2
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Over 18 yrs with ocular hypertension or open-angle glaucoma
- Subjects who have a best-corrected visual acuity of 20/100 or better.
Exclusion criteria
- Subjects who wear contact lenses.
- Uncontrolled medical conditions
- Subjects requiring chronic topical artificial tears, lubricants, and/or requiring any other chronic topical medications.
- Subjects who have a history of chronic or recurrent inflammatory eye disease.
Treatment and study plan
Latanoprost-PPDS
DrugControl of IOP compared to baseline for the experimental doses of Latanoprost-PPDS for 4 months or until loss of efficacy.
Primary outcomes
-
IOP change from baseline
Time frame: 6 weeks
Sponsors and collaborators
Lead sponsor
Mati Therapeutics Inc.
Industry
Registry information
Official study title
An Open-Label, Phase 2 Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension (OH) or Open Angle Glaucoma (OAG)
Important dates
- Study start
- 2009
- Primary completion
- 2009
- Study completion
- 2009
- First posted
- Jan 12, 2009
- Registry last updated
- Sep 19, 2013
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
SD-OCT Multimodal Analysis in GLaucoma
NCT02710916
Eye Diseases, Glaucoma
Bordeaux, Aquitaine, France
View Trial Details24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring
NCT06689696
Eye Diseases, GLAUCOMA 1, OPEN ANGLE, D (Disorder)
Fullerton, California, United States
View Trial DetailsEfficacy and Safety Assessment of T4090 Ophthalmic Solution Versus Rhopressa® Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension
NCT06394973
Eye Diseases, Glaucoma
Glendale, Arizona, United States
View Trial DetailsEvaluation of the Safety and Effectiveness of the Bimatoprost Implant System / IOL Combination in Patients With Ocular Hypertension or Mild to Moderate Open-angle Glaucoma
NCT07154797
Cataract, Eye Diseases
Santa Rosa de Copán, Honduras
View Trial Details